Your browser doesn't support javascript.
loading
Methodological Validation of Sedimentation Velocity Analytical Ultracentrifugation Method for Adeno-Associated Virus and Collaborative Calibration of System Suitability Substance.
Qin, Xi; Yu, Qikun; Li, Xiang; Jiang, Wei; Shi, Xinchang; Hou, Wenxiu; Zhang, Da; Cai, Zhenzhen; Bi, Hua; Fan, Wenhong; Ding, Youxue; Yang, Yichen; Dong, Biao; Chen, Long; Huo, Dehua; Wang, Cong; Zhou, Yong; Pei, Dening; Ye, Miao; Liang, Chenggang.
Afiliación
  • Qin X; National Institutes for Food and Drug Control, Beijing, China.
  • Yu Q; Beckman Coulter, Inc., Shanghai, Republic of China.
  • Li X; National Institutes for Food and Drug Control, Beijing, China.
  • Jiang W; Belief BioMed Inc., Shanghai, Republic of China.
  • Shi X; National Institutes for Food and Drug Control, Beijing, China.
  • Hou W; Belief BioMed Inc., Shanghai, Republic of China.
  • Zhang D; Skyline Therapeutics (Shanghai) Co., Ltd., Shanghai, Republic of China.
  • Cai Z; Belief BioMed Inc., Shanghai, Republic of China.
  • Bi H; National Institutes for Food and Drug Control, Beijing, China.
  • Fan W; National Institutes for Food and Drug Control, Beijing, China.
  • Ding Y; National Institutes for Food and Drug Control, Beijing, China.
  • Yang Y; Beckman Coulter, Inc., Shanghai, Republic of China.
  • Dong B; Sichuan Real & Best Biotech Co., Ltd., Chengdu, Republic of China.
  • Chen L; Wuhan Neurophth Biotechnology Limited Company, Wuhan, Republic of China.
  • Huo D; Beckman Coulter, Inc., Shanghai, Republic of China.
  • Wang C; Beckman Coulter, Inc., Shanghai, Republic of China.
  • Zhou Y; National Institutes for Food and Drug Control, Beijing, China.
  • Pei D; National Institutes for Food and Drug Control, Beijing, China.
  • Ye M; Beckman Coulter, Inc., Shanghai, Republic of China.
  • Liang C; National Institutes for Food and Drug Control, Beijing, China.
Hum Gene Ther ; 35(11-12): 401-411, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38717948
ABSTRACT
Currently, adeno-associated virus (AAV) is one of the primary gene delivery vectors in gene therapy, facilitating long-term in vivo gene expression. Despite being imperative, it is incredibly challenging to precisely assess AAV particle distribution according to the sedimentation coefficient and identify impurities related to capsid structures. This study performed the systematic methodological validation of quantifying the AAV empty and full capsid ratio. This includes specificity, accuracy, precision, linearity, and parameter variables involving the sedimentation velocity analytical ultracentrifugation (SV-AUC) method. Specifically, SV-AUC differentiated among the empty, partial, full, and high sedimentation coefficient substance (HSCS) AAV particles while evaluating their sedimentation heterogeneity. The intermediate precision analysis of HE (high percentage of empty capsid) and HF (high percentage of full capsid) samples revealed that the specific species percentage, such as empty or full, was more significant than 50%. Moreover, the relative standard deviation (RSD) could be within 5%. Even for empty or partially less than 15%, the RSD could be within 10%. The accuracy recovery rates of empty capsid were between 103.9% and 108.7% across three different mixtures. When the measured percentage of specific species was more significant than 14%, the recovery rate was between 77.9% and 106.6%. Linearity analysis revealed an excellent linear correlation between the empty, partial, and full in the HE samples. The AAV samples with as low as 7.4 × 1011 cp/mL AAV could be accurately quantified with SV-AUC. The parameter variable analyses revealed that variations in cell alignment significantly affected the overall results. Still, the detection wavelength of 235 nm slightly influenced the empty, partial, and full percentages. Minor detection wavelength changes showed no impact on the sedimentation coefficient of these species. However, the temperature affected the measured sedimentation coefficient. These results validated the SV-AUC method to quantify AAV. This study provides solutions to AAV empty and full capsid ratio quantification challenges and the subsequent basis for calibrating the AAV empty capsid system suitability substance. Because of the AAV structure and potential variability complexity in detection, we jointly calibrated empty capsid system suitability substance with three laboratories to accurately detect the quantitative AAV empty and full capsid ratio. The empty capsid system suitability substance could be used as an external reference to measure the performance of the instrument. The results could be compared with multiple QC (quality control) laboratories based on the AAV vector and calibration accuracy. This is crucial for AUC to be used for QC release and promote gene therapy research worldwide.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ultracentrifugación / Dependovirus / Vectores Genéticos Límite: Humans Idioma: En Revista: Hum Gene Ther Asunto de la revista: GENETICA MEDICA / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ultracentrifugación / Dependovirus / Vectores Genéticos Límite: Humans Idioma: En Revista: Hum Gene Ther Asunto de la revista: GENETICA MEDICA / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: China